Text Size

Cone Beam CT Scanning in Lung and Bladder Cancer.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Alberta Health Services
ClinicalTrials.gov Identifier:
NCT00469066
First received: May 2, 2007
Last updated: December 8, 2011
Last verified: December 2011
History of Changes
  Purpose

To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.


Condition
Lung Neoplasm
Small Cell Carcinoma
Bladder Carcinoma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Improving the Accuracy of Radiotherapy Planning and Delivery Using Kilovoltage Cone Beam CT Imaging

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Alberta Health Services:

Enrollment: 22
Study Start Date: May 2007
Study Completion Date: April 2010
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

primary care clniic

Criteria

Inclusion Criteria:

  • Patient has biopsy proven limited stage SCLC
  • receiving radical concurrent chemoradiotherapy
  • no prior chest RT
  • no prior surgical resection of lung tumor
  • no prior chemotherapy
  • patients' lung tumors should be centrally-located to minimize the effect of respiratory motion
  • patient has biopsy proven TCC bladder
  • receiving radical concurrent chemoradiotherapy or RT alone
  • no prior chemotherapy
  • patient signs study-specific consent form

Exclusion Criteria:

  • mixed small cell and non small cell histology
  • patient not being treated with concurrent chemoradiotherapy
  • chemoradiotherapy given sequentially
  • previous chest RT
  • previous chemotherapy
  • prior surgical resection of lung mass
  • patient ineligible for pelvic RT
  • patient does not sign study consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00469066

Locations
Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada
Sponsors and Collaborators
Alberta Health Services
Investigators
Principal Investigator: Don Yee, MD Alberta Health Services
  More Information

No publications provided

Responsible Party: Alberta Health Services
ClinicalTrials.gov Identifier: NCT00469066     History of Changes
Other Study ID Numbers: LU-11-0073
Study First Received: May 2, 2007
Last Updated: December 8, 2011
Health Authority: Canada: Health Canada

Keywords provided by Alberta Health Services:
small cell lung cancer
bladder cancer
conformal radiotherapy

Additional relevant MeSH terms:
Urinary Bladder Neoplasms
Neoplasms
Carcinoma
Lung Neoplasms
Small Cell Lung Carcinoma
Carcinoma, Small Cell
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Urinary Bladder Diseases
 Urologic Diseases
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Respiratory Tract Neoplasms
Thoracic Neoplasms
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms

ClinicalTrials.gov processed this record on May 21, 2013